123788-44-3 Usage
Description
CHEMBRDG-BB 6019641, with the molecular formula C12H22O11, is a polyol sugar alcohol that serves as a versatile compound with applications in various industries, particularly food and pharmaceuticals. Known for its high solubility in water and generally recognized as safe for consumption, it is a popular alternative to traditional sugars, especially for those with dietary restrictions. Its potential antioxidant and antimicrobial properties further enhance its value in the development of new products.
Uses
Used in Food Industry:
CHEMBRDG-BB 6019641 is used as a sweetener, humectant, and thickening agent in food products. Its ability to retain moisture and add bulk without significantly raising blood sugar levels makes it an ideal ingredient for a wide range of food items, including those catering to health-conscious consumers and individuals with specific dietary needs.
Used in Pharmaceutical Industry:
CHEMBRDG-BB 6019641 is used as an ingredient in medications such as cough syrups and lozenges. Its properties as a sweetener and humectant contribute to the palatability and effectiveness of these medicinal products, providing relief and comfort to patients.
Given its potential antioxidant and antimicrobial properties, CHEMBRDG-BB 6019641 may also find applications in the development of new food and pharmaceutical products, where these characteristics can enhance the health benefits and shelf life of the final products.
Check Digit Verification of cas no
The CAS Registry Mumber 123788-44-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,7,8 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 123788-44:
(8*1)+(7*2)+(6*3)+(5*7)+(4*8)+(3*8)+(2*4)+(1*4)=143
143 % 10 = 3
So 123788-44-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H11BrN2O/c1-6(2)9(13)12-8-4-3-7(10)5-11-8/h3-6H,1-2H3,(H,11,12,13)
123788-44-3Relevant articles and documents
MRGPRX2 ANTAGONISTS AND USES THEREOF
-
Paragraph 00142-00143; 00210-00211, (2021/05/15)
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.
